IT1262912B - Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro - Google Patents

Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro

Info

Publication number
IT1262912B
IT1262912B ITFI920241A ITFI920241A IT1262912B IT 1262912 B IT1262912 B IT 1262912B IT FI920241 A ITFI920241 A IT FI920241A IT FI920241 A ITFI920241 A IT FI920241A IT 1262912 B IT1262912 B IT 1262912B
Authority
IT
Italy
Prior art keywords
melatonin
sarcoidosis
systemic sclerosis
sclerosis therapy
therapy
Prior art date
Application number
ITFI920241A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITFI920241A priority Critical patent/IT1262912B/it
Publication of ITFI920241A0 publication Critical patent/ITFI920241A0/it
Priority to DE69311286T priority patent/DE69311286T2/de
Priority to EP93830535A priority patent/EP0605371B1/en
Publication of ITFI920241A1 publication Critical patent/ITFI920241A1/it
Application granted granted Critical
Publication of IT1262912B publication Critical patent/IT1262912B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Terapia della sclerosi sistematica e della sarcoidosi con l'impiego di melatonina in dose giornaliera unica dell'ordine di 20 mgr. somministrata nell'arco di tempo dalle ore 18 alle ore 20.
ITFI920241A 1992-12-30 1992-12-30 Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro IT1262912B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITFI920241A IT1262912B (it) 1992-12-30 1992-12-30 Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro
DE69311286T DE69311286T2 (de) 1992-12-30 1993-12-30 Verwendung von Melatonin zur Herstellung eines Arzneimittels zur Behandlung von Scleroderma und der Sarcoidosis
EP93830535A EP0605371B1 (en) 1992-12-30 1993-12-30 Use of melatonin for the manufacture of a medicament for the treatment of scleroderma and sarcoidosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920241A IT1262912B (it) 1992-12-30 1992-12-30 Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro

Publications (3)

Publication Number Publication Date
ITFI920241A0 ITFI920241A0 (it) 1992-12-30
ITFI920241A1 ITFI920241A1 (it) 1994-06-30
IT1262912B true IT1262912B (it) 1996-07-22

Family

ID=11350271

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920241A IT1262912B (it) 1992-12-30 1992-12-30 Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro

Country Status (3)

Country Link
EP (1) EP0605371B1 (it)
DE (1) DE69311286T2 (it)
IT (1) IT1262912B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711553A1 (en) * 1994-08-09 1996-05-15 Mario Cagnoni Use of the Melatonin in the traetment of the articular symptoms of trheumatoid arthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
ITFI920241A1 (it) 1994-06-30
EP0605371A1 (en) 1994-07-06
EP0605371B1 (en) 1997-06-04
ITFI920241A0 (it) 1992-12-30
DE69311286D1 (de) 1997-07-10
DE69311286T2 (de) 1997-10-30

Similar Documents

Publication Publication Date Title
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
MD1663B2 (en) Composition and methods for human sexual activity modulation and impotency treatment
DE69320485D1 (de) VERWENDUNG VON MELATONIN in niedrigen oralen Dosen ZUM HERBEIFÜHREN VON SCHLAF
MY103212A (en) Zinc-protamine-alpha interferon complex
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
ES2040106T3 (es) Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
DK0702560T3 (da) Immunforstærkning ved intermitterende interleukin-2 behandling
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
ZA95463B (en) Use of interleukin-12 to prevent graft-versus-host disease
AU4786093A (en) Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
DE69113982D1 (de) Neue 15,16-seco-19-nor-progestine.
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
GR3023021T3 (en) Synergising association having an antagonist effect on nk1 and nk2 receptors.
MY103872A (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function.
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ES8403884A1 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
IT1262912B (it) Impiego della melatonina nella terapia della sclerosi sistemica, della sarcoidosi ed altro
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
PL334093A1 (en) Application of comt inhibitors in production of drugs preventing occurence of vascular disorders in case of diabetes
NZ332690A (en) Stimulation of host defence mechanisms against viral challenges using interferon
IT8819559A0 (it) Impiego terapeutico dell'acido uridinfosfoglucuronico (udpg_a)come attivatore della glucuronconiugazione del trattamento di epatopie ed itteri.
ATE224729T1 (de) Verwendung von hyaluronidase

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981223